FDA NDC Directory · JSON-LD · Markdown

Fluticasone propionate and Salmeterol

NDC 69097-662 · HUMAN PRESCRIPTION DRUG · POWDER

Labeler / ManufacturerCipla USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA213087
Dosage form / routePOWDER · RESPIRATORY (INHALATION)
Active ingredientsFLUTICASONE PROPIONATE (100 ug/1)
SALMETEROL XINAFOATE (50 ug/1)
Marketing started20260727
Package count1

External sources

Source: openFDA. Public-domain (CC0).